help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 25, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1975
A more recent version of this article appeared on January 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/1/196    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazzuco, T. L.
Right arrow Articles by Thomas, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazzuco, T. L.
Right arrow Articles by Thomas, M.

Submitted on September 1, 2005
Accepted on October 17, 2005

Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features

Tania L. Mazzuco, Olivier Chabre, Jean-Jacques Feige, and Michaël Thomas*

Institut National de la Santé et de la Recherche Médicale, Equipe Mixte 105, Département Réponse et Dynamique Cellulaires, Commissariat à l'Energie Atomique, 17 rue des Martyrs, 38054 Grenoble, Cedex 09, France and Service d'Endocrinologie, Département de Diabétologie, Urologie, Néphrologie et Endocrinologie, Centre Hospitalier Universitaire, Grenoble, France

* To whom correspondence should be addressed. E-mail: michael.thomas{at}cea.fr.

Context: Aberrant expression of LH/hCG receptor has been suggested in several cases of bilateral macronodular adrenal hyperplasia with Cushing's syndrome. The cortisol production is then directly controlled by endogenous secretion of LH/hCG. However, the direct involvement of this aberrant LH/hCG receptor expression in the development of the hyperplasia has not been demonstrated. Moreover in most cases, whenever investigated, the aberrant expression of LH/hCG receptor has been associated with the ectopic expression of other G protein-coupled receptors such as gastric inhibitory polypeptide, serotonin or vasopressin receptors.

Objective: The aim of this study was to explore the action of LH/hCG receptor on the development of adrenal hyperplasia.

Results: The ectopic expression of this single non-mutated gene transduced into bovine adrenocortical cells was sufficient to induce not only the aberrant cortisol secretion but also hyperproliferation and benign transformation. The cells were transplanted beneath the kidney capsule of adrenalectomized immunodeficient mice. Only the cells expressing the LH/hCG receptor gene formed an enlarged tissue with a high proliferation rate. The tissue expressing LH/hCG receptor was responsible for elevated plasma cortisol and decreased plasma ACTH levels in transplanted mice. These animals displayed physiological changes similar to those of patients with Cushing's syndrome, including muscle atrophy, thin skin, spleen atrophy and hyperglycemia.

Conclusions: These results demonstrate that a single genetic event such as the inappropriate expression of the non-mutated LH/hCG receptor gene is sufficient to initiate the phenotypic changes that cause the development of a benign adrenocortical tumor.


Key words: LH/hCG receptor • hypercortisolism • adrenal tumorigenesis • hyperplasia • Cushing's syndrome • xenotransplantation




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
S. Vuorenoja, A. Rivero-Muller, A. J Ziecik, I. Huhtaniemi, J. Toppari, and N. A Rahman
Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin {beta} conjugate
Endocr. Relat. Cancer, June 1, 2008; 15(2): 635 - 648.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Bernichtein, E. Petretto, S. Jamieson, A. Goel, T. J. Aitman, J. M. Mangion, and I. T. Huhtaniemi
Adrenal Gland Tumorigenesis after Gonadectomy in Mice Is a Complex Genetic Trait Driven by Epistatic Loci
Endocrinology, February 1, 2008; 149(2): 651 - 661.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
E Louiset, V Contesse, L Groussin, D Cartier, C Duparc, V Perraudin, J Bertherat, and H Lefebvre
Expression of vasopressin receptors in ACTH-independent macronodular bilateral adrenal hyperplasia causing Cushing's syndrome: molecular, immunohistochemical and pharmacological correlates
J. Endocrinol., January 1, 2008; 196(1): 1 - 9.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
N M Albiger, G Occhi, B Mariniello, M Iacobone, G Favia, A Fassina, D Faggian, F Mantero, and C Scaroni
Food-dependent Cushing's syndrome: from molecular characterization to therapeutical results
Eur. J. Endocrinol., December 1, 2007; 157(6): 771 - 778.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P. Ye, B. Mariniello, F. Mantero, H. Shibata, and W. E Rainey
G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism
J. Endocrinol., October 1, 2007; 195(1): 39 - 48.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. D. Looyenga and G. D. Hammer
Origin and Identity of Adrenocortical Tumors in Inhibin Knockout Mice: Implications for Cellular Plasticity in the Adrenal Cortex
Mol. Endocrinol., November 1, 2006; 20(11): 2848 - 2863.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Louiset, V. Contesse, L. Groussin, D. Cartier, C. Duparc, G. Barrande, J. Bertherat, H. Vaudry, and H. Lefebvre
Expression of Serotonin7 Receptor and Coupling of Ectopic Receptors to Protein Kinase A and Ionic Currents in Adrenocorticotropin-Independent Macronodular Adrenal Hyperplasia Causing Cushing's Syndrome
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4578 - 4586.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. Alevizaki, K. Saltiki, E. Mantzou, E. Anastasiou, and I. Huhtaniemi
The adrenal gland may be a target of LH action in postmenopausal women.
Eur. J. Endocrinol., June 1, 2006; 154(6): 875 - 881.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society